ALLR
Allarity Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.87
−2.46%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.21
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$0.25
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +17.4%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.25 | -$0.21 | Beat 16.00% | — |
| May 15, 2026 | -$0.22 | -$0.17 | Beat 22.73% | $25.0K |
| Mar 31, 2026 | -$0.22 | -$0.19 | Beat 13.64% | $320.0K |
| Nov 14, 2025 | -$0.23 | -$0.19 | Beat 17.39% | — |
| Aug 15, 2025 | -$0.21 | -$0.15 | Beat 28.57% | — |
| May 9, 2025 | — | -$0.25 | — | — |
| Nov 14, 2024 | -$8.52 | -$7.71 | Beat 9.51% | — |
| Nov 14, 2023 | -$8.17 | -$1.3K | Miss -16366.95% | — |
| Aug 14, 2023 | -$11 | -$15.8K | Miss -140952.55% | — |
| May 11, 2023 | -$7.88 | -$106.4K | Miss -1350488.96% | — |
| Mar 13, 2023 | -$0.42 | -$0.23 | Beat 45.24% | — |
| Nov 14, 2022 | -$218.4K | -$571.2K | Miss -161.54% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026